Release Date: 15/06/22 11:20 Summary: Announcement under ASX Operating Rule 10A.4.3 Price Sensitive: No Download Document 104.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%